Charles S. Morrow

3.2k total citations
62 papers, 2.7k citations indexed

About

Charles S. Morrow is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Charles S. Morrow has authored 62 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 21 papers in Oncology and 7 papers in Biochemistry. Recurrent topics in Charles S. Morrow's work include Glutathione Transferases and Polymorphisms (32 papers), Genomics, phytochemicals, and oxidative stress (28 papers) and Drug Transport and Resistance Mechanisms (21 papers). Charles S. Morrow is often cited by papers focused on Glutathione Transferases and Polymorphisms (32 papers), Genomics, phytochemicals, and oxidative stress (28 papers) and Drug Transport and Resistance Mechanisms (21 papers). Charles S. Morrow collaborates with scholars based in United States, Australia and Canada. Charles S. Morrow's co-authors include Alan J. Townsend, Kenneth H. Cowan, Pamela K. Smitherman, K H Cowan, Merrill E. Goldsmith, Mary Madden, Christian M. Paumi, Suzy V. Torti, Susan P. Whitman and Yoshiaki Tsuji and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Annals of Internal Medicine.

In The Last Decade

Charles S. Morrow

58 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles S. Morrow United States 32 1.8k 813 306 257 238 62 2.7k
Alan J. Townsend United States 33 1.9k 1.1× 756 0.9× 233 0.8× 120 0.5× 322 1.4× 60 2.7k
Jeffrey A. Moscow United States 35 1.8k 1.0× 1.0k 1.3× 200 0.7× 210 0.8× 335 1.4× 94 3.6k
M. Tien Kuo United States 37 2.1k 1.2× 1.4k 1.7× 282 0.9× 191 0.7× 579 2.4× 87 3.6k
Shigeki Tsuchida Japan 30 2.3k 1.3× 631 0.8× 282 0.9× 155 0.6× 358 1.5× 116 3.2k
Shin-ichi Akiyama Japan 27 1.2k 0.7× 1.6k 2.0× 105 0.3× 154 0.6× 254 1.1× 47 2.5k
A Amar-Costesec Belgium 19 1.6k 0.9× 527 0.6× 236 0.8× 112 0.4× 81 0.3× 43 2.8k
Setsuro Fujii Japan 23 1.1k 0.6× 834 1.0× 142 0.5× 140 0.5× 259 1.1× 119 2.8k
Rosa M. Pascale Italy 37 2.5k 1.4× 705 0.9× 334 1.1× 65 0.3× 934 3.9× 112 3.9k
Alakananda Basu United States 36 3.3k 1.8× 1.4k 1.7× 88 0.3× 368 1.4× 606 2.5× 109 5.1k
Donald J. Svoboda United States 27 1.2k 0.7× 357 0.4× 200 0.7× 290 1.1× 214 0.9× 47 2.4k

Countries citing papers authored by Charles S. Morrow

Since Specialization
Citations

This map shows the geographic impact of Charles S. Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Morrow more than expected).

Fields of papers citing papers by Charles S. Morrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Morrow. The network helps show where Charles S. Morrow may publish in the future.

Co-authorship network of co-authors of Charles S. Morrow

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Morrow. A scholar is included among the top collaborators of Charles S. Morrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Morrow. Charles S. Morrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lok, Hiu Chuen, Yohan Suryo Rahmanto, Clare L. Hawkins, et al.. (2011). Nitric Oxide Storage and Transport in Cells Are Mediated by Glutathione S-Transferase P1-1 and Multidrug Resistance Protein 1 via Dinitrosyl Iron Complexes. Journal of Biological Chemistry. 287(1). 607–618. 50 indexed citations
3.
Smitherman, Pamela K., et al.. (2008). Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane. Carcinogenesis. 29(4). 807–815. 25 indexed citations
4.
5.
Morrow, Charles S., et al.. (2006). Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediates Resistance to Mitoxantrone via Glutathione-Dependent Drug Efflux. Molecular Pharmacology. 69(4). 1499–1505. 76 indexed citations
6.
O’Flaherty, Joseph T., LeAnn C. Rogers, Christian M. Paumi, et al.. (2005). 5-Oxo-ETE analogs and the proliferation of cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1736(3). 228–236. 55 indexed citations
7.
Riddick, David S., Chunja Lee, Edwin C. Chinje, et al.. (2005). CANCER CHEMOTHERAPY AND DRUG METABOLISM. Drug Metabolism and Disposition. 33(8). 1083–1096. 57 indexed citations
8.
Smitherman, Pamela K., Alan J. Townsend, Timothy E. Kute, & Charles S. Morrow. (2004). Role of Multidrug Resistance Protein 2 (MRP2, ABCC2) in Alkylating Agent Detoxification: MRP2 Potentiates Glutathione S-Transferase A1-1-Mediated Resistance to Chlorambucil Cytotoxicity. Journal of Pharmacology and Experimental Therapeutics. 308(1). 260–267. 77 indexed citations
9.
Paumi, Christian M., Marcus W. Wright, Alan J. Townsend, & Charles S. Morrow. (2003). Multidrug Resistance Protein (MRP) 1 and MRP3 Attenuate Cytotoxic and Transactivating Effects of the Cyclopentenone Prostaglandin, 15-Deoxy-Δ12,14Prostaglandin J2 in MCF7 Breast Cancer Cells. Biochemistry. 42(18). 5429–5437. 61 indexed citations
10.
Townsend, Alan J., et al.. (2002). Modeling the metabolic competency of glutathione S-transferases using genetically modified cell lines. Toxicology. 181-182. 265–269. 9 indexed citations
11.
Paumi, Christian M., et al.. (2001). Role of Multidrug Resistance Protein 1 (MRP1) and Glutathione S-Transferase A1-1 in Alkylating Agent Resistance. Journal of Biological Chemistry. 276(11). 7952–7956. 85 indexed citations
12.
Smitherman, Pamela K., Julie Aldridge, Erin L. Volk, et al.. (2001). Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins.. PubMed. 61(14). 5461–7. 53 indexed citations
13.
Morrow, Charles S., Pamela K. Smitherman, & Alan J. Townsend. (2000). Role of multidrug-resistance protein 2 in glutathioneS-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells. Molecular Carcinogenesis. 29(3). 170–178. 53 indexed citations
14.
Morrow, Charles S., et al.. (1998). Coordinated Action of Glutathione S-Transferases (GSTs) and Multidrug Resistance Protein 1 (MRP1) in Antineoplastic Drug Detoxification. Journal of Biological Chemistry. 273(32). 20114–20120. 118 indexed citations
15.
16.
17.
Yokomizo, Akira, Kimitoshi Kohno, Morimasa Wada, et al.. (1995). Markedly Decreased Expression of Glutathione S-Transferase π Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis. Journal of Biological Chemistry. 270(33). 19451–19457. 31 indexed citations
18.
Morrow, Charles S. & Kenneth H. Cowan. (1993). Antineoplastic Drug Resistance and Breast Cancer. Annals of the New York Academy of Sciences. 698(1). 289–312. 20 indexed citations
19.
Townsend, Alan J., Charles S. Morrow, Birandra K. Sinha, & Kenneth H. Cowan. (1991). Selenium-Dependent Glutathione Peroxidase Expression is Inversely Related to Estrogen Receptor Content of Human Breast Cancer Cells. PubMed. 3(8). 265–270. 13 indexed citations
20.
Morrow, Charles S., Kenneth H. Cowan, & Merrill E. Goldsmith. (1989). Structure of the human genomic glutathione S-transferase-π gene. Gene. 75(1). 3–11. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan J. Townsend Breakdown of academic impact, for papers by Jeffrey A. Moscow Breakdown of academic impact, for papers by M. Tien Kuo Breakdown of academic impact, for papers by Shigeki Tsuchida Breakdown of academic impact, for papers by Shin-ichi Akiyama Breakdown of academic impact, for papers by A Amar-Costesec Breakdown of academic impact, for papers by Setsuro Fujii Breakdown of academic impact, for papers by Rosa M. Pascale Breakdown of academic impact, for papers by Alakananda Basu Breakdown of academic impact, for papers by Donald J. Svoboda
Rankless by CCL
2026